Printer Friendly

TRANS-ATLANTIC ALLIANCE TO ADVANCE SKIN DISORDER RESEARCH AND TREATMENT

 CHADDS FORD, Pa., Nov. 24 ~PRNewswire~ -- Supra Medical Corp. (AMEX: SUM.EC), formerly Topox, Inc., announced today that it had formalized its prior understanding with the United Medical and Dental Schools (UMDS) of Guy's and St. Thomas' Hospitals, University of London, to establish jointly Supra Medical International, Ltd. Jack Cantwell, chairman and chief executive officer said, "For months, we have been preparing for this event. The wonder is not the length of the delay since signing the letter of intent with UMDS, but rather how much has been accomplished pending this agreement."
 One of the initial goals of Supra Medical's majority owned joint venture is the establishment of a Wound Healing Clinic at Guy's Hospital which would serve as the prototype for wound healing "Centers of Excellence" the world over. To insure the achievement of this objective, a separate Wound Healing Research Group will be formed at UMDS under the leadership of Dr. Mary Dyson whose Tissue Repair Research Unit at UMDS has already established a world class presence in wound healing research. Cantwell said, "Now it is expected that several other wound healing clinics in the U.K. will shortly join the 'Centers of Excellence' roster."
 "On the medical science frontier, there has been a most promising development," commented Evelyna Dyson-Cantwell, president of Supra Medical Corp. "Until now, we have been concentrating on the wound segment of skin disorders because of the natural synergy between our ultrasound scanners and our topical hyperbaric oxygen chambers. Remaining to be explored are many dermatologic conditions that afflict millions upon millions of persons." She announced that through the auspices of Supra Medical International, Ltd. dermatologic research will be accelerated considerably. She stated, "We have been most fortunate in attracting the interest and support of Professor Malcolm W. Greaves, a world renowned researcher in skin diseases. He is the Dean of St. John's Institute of Dermatology at UMDS and is based at St. Thomas' Hospital. With the Supra Scanner(R), he and his colleagues will be able to explore the applicability of high frequency ultrasound diagnostics to a wide variety of dermatologic conditions."
 Cantwell observed, "We take it as highest testimony to Supra Medical Corp. and its products that UMDS and its research personnel would choose to join us in this venture. The United Medical and Dental Schools is the largest single-faculty medical and dental school within the University of London, which itself is the largest and most diverse university in Britain. Guy's and St. Thomas' Hospitals are world famous and distinguished by centuries-old traditions of clinical and academic excellence."
 Dyson-Cantwell said, "Our company's advances in high frequency ultrasound and topical oxygen have put a number of developments in skin disorder diagnostics and healing on a fast track. Our intent is to further speed these developments through collaboration with distinguished researchers and care givers in our areas of interest. The medical need is great, and so is the commercial opportunity."
 Mary Dyson added, "The medical science of skin disorders has long been shackled by the inability to explore in a non-invasive manner what is happening under the surface of wounds and other dermatologic conditions. Now, we can not only see, but see with great precision. The impact should be considerable." In addition to Dyson (BSc PhD MlBiol CBiol FAIUM FCSP FZS), the Wound Healing Research Group staff will benefit from the expertise of Dr. Steven R. Young (BSc PhD), Dr. Patricia A. Reynolds (BDS MBBS FDSRCS (Eng)) and Peter A. Bolton (BSc CBiol, MlBiol FLS FRSM FZS) and other members of the Tissue Repair Research Unit.
 Cantwell stated, "Our next step will be the funding of Supra Medical International, Ltd. in the U.K. The directors for the proposed company will be Jack Cantwell, George Stasen, Dr. Mary Dyson and David Morton (UMDS Director of Finance). We envision that Supra Medical International will ultimately provide a wide variety of products and services to the U.K. and European medical markets. We see opportunities not only for greater medical efficacy, but at real cost savings."
 Supra Medical Corp. develops and markets proprietary medical products which are used in the diagnosis, monitoring and ongoing treatment of skin disorders such as wounds, ulcerations, burns and other skin disorders including skin cancers and melanomas.
 For additional information, contact George J. Stasen, chief operating officer and executive vice president, Supra Medical Corp., Chadds Ford Business Campus, 106 Brandywine Two, Chadds Ford, Pa., 19317. Telephone: 1-800-388-6769.
 ~delval~
 -0- 11~24~92
 ~CONTACT: George Stasen of Supra Medical Corp., 800-388-6769~
 (SUM)


CO: Supra Medical Corp. ST: Pennsylvania IN: HEA SU: JVN

MJ-JS -- PH024 -- 1024 11~24~92 11:32 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 24, 1992
Words:769
Previous Article:AIR PRODUCTS RAISING MERCHANT INDUSTRIAL GAS PRICES IN WESTERN STATES
Next Article:BOEING TO TRIM 757 AND 767 PRODUCTION RATES
Topics:


Related Articles
TOPOX: AGREEMENT SIGNED TO MANUFACTURE INNOVATIVE MEDICAL DEVICES
NASA PROJECT TO FURTHER ULTRASOUND DIAGNOSTIC FRONTIERS
SUPRA MEDICAL EXPANDS NON-INVASIVE BREAST DISEASE DIAGNOSTIC PROGRAM
Genzyme Corporation, Partners HealthCare System Form Research Alliance
New Survey Shows that Women Know the Cause of Age Spots, But Don't Choose to Protect Themselves; Alliance for Aging Research Releases New Brochure to...
New Phototherapy Technology Developed in Israel to Treat Psoriasis, Vitiligo, Atopic Dermatitis and Leukoderma Gets FDA Clearance.
First Skin Pigmentation Awareness Week Launches April 26 - May 3, 2004; Dermatologists Join Forces to Raise Awareness of Common Skin Pigmentation...
Skin pigmentation affects millions.
Chloasma & vitiligo.
Reportlinker Adds Dermatological Therapeutics: Global Markets Report.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters